Skip to main content

ASCO 2019 - Chronic Lymphocytic Leukemia

ASCO 2019 - Chronic Lymphocytic Leukemia
A Systematic Review of the Efficacy of Ibrutinib-Based Combination Therapy for Mantle-Cell Lymphoma
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
SYK Inhibition with Fostamatinib in Waldenström’s Macroglobulinemia
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Ibrutinib Maintenance Following Induction for Untreated MCL: Initial Safety Report
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Phase 1/2 Trial of Cirmtuzumab plus Ibrutinib: Planned Analysis of Phase 1 CLL Cohorts
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
The ZUMA-8 Phase 1/2 Multicenter Study Evaluating KTE-X19 in Patients with Relapsed/Refractory CLL
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
A Phase 2 Study Investigating Umbralisib Monotherapy in Patients with Relapsed/Refractory MZL
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Final Analysis from RESONATE: Six-Year Follow-Up in Patients with Previously Treated CLL/SLL Receiving Ibrutinib
Read More
ASCO 2019 - Chronic Lymphocytic Leukemia
Effect of Dose Modifications on Response to Duvelisib in Patients with Relapsed/Refractory CLL/SLL in the DUO Trial
Read More
Page 2 of 2
Results 11 - 18 of 18